Amended AMNOG Sees New Life Breathed Into Trajenta Reimbursement Bid In Germany

Changes to Germany’s drug reimbursement law have permitted Boehringer Ingelheim and Eli Lilly to submit an updated dossier for their oral therapy Trajenta, giving medicine makers who operate there hope that further positive amendments will occur.